XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional paid-in capital
Accumulated other comprehensive loss
Retained earnings
Balance at beginning of period (in shares) at Dec. 31, 2022   37,692,132      
Balance at beginning of period at Dec. 31, 2022 $ 796,409 $ 377 $ 0 $ (34,338) $ 830,370
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   1,400      
Exercise of stock options 83 $ 0 83 0 0
Withholdings from vesting of restricted stock (in shares)   (61,423)      
Withholdings from vesting of restricted stock (4,776) $ (1) (4,404) 0 (371)
Restricted stock activity (in shares)   303,015      
Restricted stock activity 0 $ 3 (3) 0 0
Stock-based compensation expense 4,343 $ 0 4,343 0 0
Repurchase of common stock (in shares)   (135,873)      
Repurchase of common stock (9,586) $ (1) 0 0 (9,585)
Cash dividends declared and paid (28,483) 0 0 0 (28,483)
Comprehensive income 39,922 0 0 3,926 35,996
Other (19) $ 0 (19) 0 0
Balance at end of period (in shares) at Apr. 01, 2023   37,799,251      
Balance at end of period at Apr. 01, 2023 797,893 $ 378 0 (30,412) 827,927
Balance at beginning of period (in shares) at Dec. 31, 2022   37,692,132      
Balance at beginning of period at Dec. 31, 2022 796,409 $ 377 0 (34,338) 830,370
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income $ 131,186        
Balance at end of period (in shares) at Sep. 30, 2023 36,969,967 36,969,967      
Balance at end of period at Sep. 30, 2023 $ 785,311 $ 370 0 (29,142) 814,083
Balance at beginning of period (in shares) at Apr. 01, 2023   37,799,251      
Balance at beginning of period at Apr. 01, 2023 797,893 $ 378 0 (30,412) 827,927
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Withholdings from vesting of restricted stock (in shares)   (932)      
Withholdings from vesting of restricted stock (61) $ 0 (61) 0 0
Restricted stock activity (in shares)   5,626      
Restricted stock activity 0 $ 0 0 0 0
Stock-based compensation expense 6,641 $ 0 6,641 0 0
Repurchase of common stock (in shares)   (449,481)      
Repurchase of common stock (30,336) $ (4) (6,294) 0 (24,038)
Cash dividends declared and paid (28,158) 0 0 0 (28,158)
Comprehensive income 29,316 0 0 5,449 23,867
Other (286) $ 0 (286) 0 0
Balance at end of period (in shares) at Jul. 01, 2023   37,354,464      
Balance at end of period at Jul. 01, 2023 775,009 $ 374 0 (24,963) 799,598
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   4,400      
Exercise of stock options 301 $ 0 301 0 0
Withholdings from vesting of restricted stock (in shares)   (2,359)      
Withholdings from vesting of restricted stock (170) $ 0 (170) 0 0
Restricted stock activity (in shares)   3,466      
Restricted stock activity 0 $ 0 0 0 0
Stock-based compensation expense 3,928 $ 0 3,928 0 0
Repurchase of common stock (in shares)   (390,004)      
Repurchase of common stock (27,570) $ (4) (3,786) 0 (23,780)
Cash dividends declared and paid (27,862) 0 0 0 (27,862)
Comprehensive income 61,948 0 0 (4,179) 66,127
Other $ (273) $ 0 (273) 0 0
Balance at end of period (in shares) at Sep. 30, 2023 36,969,967 36,969,967      
Balance at end of period at Sep. 30, 2023 $ 785,311 $ 370 0 (29,142) 814,083
Balance at beginning of period (in shares) at Dec. 30, 2023 36,551,221 36,551,221      
Balance at beginning of period at Dec. 30, 2023 $ 845,250 $ 366 0 (23,915) 868,799
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   4,408      
Exercise of stock options 367 $ 0 367 0 0
Withholdings from vesting of restricted stock (in shares)   (90,922)      
Withholdings from vesting of restricted stock (7,378) $ (1) (5,535) 0 (1,842)
Restricted stock activity (in shares)   243,120      
Restricted stock activity 0 $ 2 (2) 0 0
Stock-based compensation expense 5,170 $ 0 5,170 0 0
Repurchase of common stock (in shares)   (107,795)      
Repurchase of common stock (8,999) $ (1) 0 (8,998)
Cash dividends declared and paid (29,338) 0 0 0 (29,338)
Comprehensive income 36,281 $ 0 0 (1,752) 38,033
Balance at end of period (in shares) at Mar. 30, 2024   36,600,032      
Balance at end of period at Mar. 30, 2024 $ 841,353 $ 366 0 (25,667) 866,654
Balance at beginning of period (in shares) at Dec. 30, 2023 36,551,221 36,551,221      
Balance at beginning of period at Dec. 30, 2023 $ 845,250 $ 366 0 (23,915) 868,799
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income $ 115,546        
Balance at end of period (in shares) at Sep. 28, 2024 36,038,814 36,038,814      
Balance at end of period at Sep. 28, 2024 $ 829,340 $ 360 0 (32,361) 861,341
Balance at beginning of period (in shares) at Mar. 30, 2024   36,600,032      
Balance at beginning of period at Mar. 30, 2024 841,353 $ 366 0 (25,667) 866,654
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Withholdings from vesting of restricted stock (in shares)   (839)      
Withholdings from vesting of restricted stock (58) $ 0 (58) 0 0
Restricted stock activity (in shares)   34,956      
Restricted stock activity 0 $ 1 (1) 0 0
Stock-based compensation expense 4,120 $ 0 4,120 0 0
Repurchase of common stock (in shares)   (354,093)      
Repurchase of common stock (24,778) $ (4) (3,854) 0 (20,920)
Cash dividends declared and paid (29,172) 0 0 0 (29,172)
Comprehensive income 20,492 0 0 (7,147) 27,639
Other (207) $ 0 (207) 0 0
Balance at end of period (in shares) at Jun. 29, 2024   36,280,056      
Balance at end of period at Jun. 29, 2024 811,750 $ 363 0 (32,814) 844,201
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Withholdings from vesting of restricted stock (in shares)   (2,187)      
Withholdings from vesting of restricted stock (133) $ 0 (133) 0 0
Restricted stock activity (in shares)   35,480      
Restricted stock activity 0 $ 0 0 0 0
Stock-based compensation expense 4,686 $ 0 4,686 0 0
Repurchase of common stock (in shares)   (274,535)      
Repurchase of common stock (16,749) $ (3) (4,401) 0 (12,345)
Cash dividends declared and paid (28,835) 0 0 0 (28,835)
Comprehensive income 58,773 0 0 453 58,320
Other $ (152) $ 0 (152) 0 0
Balance at end of period (in shares) at Sep. 28, 2024 36,038,814 36,038,814      
Balance at end of period at Sep. 28, 2024 $ 829,340 $ 360 $ 0 $ (32,361) $ 861,341